Physician

Brett L Buchmiller, M.D.

According to 2025 Medicare claims, Brett Buchmiller, M.D. (NPI: 1558397265) practices allergy/immunology in the Everett, WA market, with the plurality of this provider's patient population coming from Snohomish, WA. This provider's primary affiliated billing organization is OPTUM CARE WASHINGTON PLLC (NPI: 1831186766; TIN: 910214500) and primary practice location at 98201-4918. Buchmiller is affiliated with the CareMount Value Partners IPA (ACO ID: D0019), participating under the REACH model.

Buchmiller's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 302 traditional Medicare patients, billed 46,294 HCPCS/CPT codes, and received $986,466 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,093 prescription claims across 186 beneficiaries totaling $2,154,061 in drug costs, led by Nucala (Mepolizumab). DME data shows 65 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $20,796 to $986,466. Similarly, Part D prescription costs have moved sharply higher in recent years, from $24,282 to $2,154,061. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	81	1,989	$20,796
2016	80	1,473	$20,111
2017	109	1,702	$27,805
2018	120	2,194	$26,981
2019	163	4,589	$78,520
2020	157	8,311	$182,432
2021	240	36,981	$613,411
2022	297	42,192	$889,950
2023	315	60,080	$1,221,810
2024	302	46,294	$986,466

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	81	308	$24,282
2016	91	430	$35,613
2017	91	447	$49,544
2018	117	550	$103,480
2019	112	626	$290,592
2020	127	680	$593,326
2021	121	733	$751,084
2022	135	711	$761,086
2023	159	912	$936,663
2024	186	1,093	$2,154,061

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	65	$87,940

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	70	176	$104
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	47	66	$81
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	48	58	$61
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	99	220	$49
J3489	Injection, zoledronic acid, 1 mg	58	290	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Nucala	Mepolizumab	50	1,400	$402,237
Dupixent Pen	Dupilumab	24	644	$102,980
Hizentra	Immun Glob G(Igg)/Pro/Iga 0-50	13	280	$70,684
Dupixent Syringe	Dupilumab	11	308	$48,528
Breo Ellipta	Fluticasone/Vilanterol	56	2,220	$30,442

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	21	$86,176
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	19	$1,457
E0779	Ambulatory infusion pump, mechanical, reusable, for infusion 8 hours or greater	Y	N/R	12	$172
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	13	$134

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Brett L. Buchmiller, M.D.?

Tedicare shows public-source Medicare data for Brett L. Buchmiller, M.D. (NPI 1558397265), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brett L. Buchmiller, M.D. have ACO affiliation data?

Brett L. Buchmiller, M.D. is shown with ACO affiliation data for CareMount Value Partners IPA (REACH, ACO ID D0019).

What billing organization is linked to Brett L. Buchmiller, M.D.?

Brett L. Buchmiller, M.D. is linked to OPTUM CARE WASHINGTON PLLC (billing NPI 1831186766) in the available physician profile data.

Does Brett L. Buchmiller, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.